This reflects a drop when compared with net income of USD1.6m (USD0.08 per share on a basic and diluted basis) for the same quarter in fiscal 2011.
Revenue of USD11.4m was generated for the quarter ended 31 December 2011, up 9% when compared with revenues of USD10.5m for the quarter ended 31 December 2010.
Non-GAAP net income of USD1.4m (USD0.07 per share) was reported for the fiscal 2012 first quarter, a growth when compared to non-GAAP net income of USD0.7m (USD0.04 per share) for the fiscal 2011 first quarter.
Bruker Corporation to acquire ELITechGroup for EUR870m, strengthening MDx portfolio
Perrigo announces quarterly dividend increase
Bruker expands Preclinical Imaging Portfolio with acquisition of Spectral Instruments Imaging
Fusion Antibodies announces receipt of follow-on project and provides R&D update
Alvotech reports positive results for AVT03, potential biosimilar to Prolia and Xgeva
Biosenic finalises agreement with Phebra for oral arsenic troxide development